Genmab | Pasivo Circulante



Current Liabilities Cambio Fecha
Agios Pharmaceuticals USD 52.37M 28.79M 2025-03
Almirall EUR 353.42M 79.41M 2024-12
Amarin USD 201.55M 28.99M 2024-09
Amgen USD 23.01B 91M 2025-03
AstraZeneca USD 29.13B 1.26B 2025-03
Bayer EUR 27.96B 993M 2025-03
BioMarin Pharmaceutical USD 628.21M 21.22M 2025-03
Demant DKK 6.1B 1.4B 2024-12
Exelixis USD 399.1M 4.67M 2025-04
Fresenius Medical Care EUR 5.45B 213.2M 2025-03
Galapagos EUR 437.04M 101.96M 2025-03
Genmab DKK 756M 4.55B 2025-03
GlaxoSmithKline GBP 20.83B 866M 2025-03
GN Store Nord DKK 7.89B 5.69B 2025-03
GRIFOLS EUR 2.17B 14.07M 2025-03
Hikma Pharmaceutical USD 1.38B 41M 2024-06
Insmed USD 239.23M 58.29M 2025-03
Lonza CHF 3.58B 970M 2024-12
Merck EUR 11.29B 831M 2024-12
Novartis USD 28.69B 560M 2024-12
Regeneron Pharmaceuticals USD 3.57B 2.13B 2025-03
Roche Holding CHF 27.02B 424M 2024-12
Sanofi 32.22B 3.06B 2025-03
UCB EUR 3.53B 731M 2024-12



Genmab Pasivo Circulante - Los valores actuales, los datos históricos, las previsiones, estadísticas, gráficas y calendario económico - May 2025.